References
Mey U, Strehl J, Gorschlüter M, Ziske C, Glasmacher A, Pralle H, et al. Advances in the treatment of hairy-cell leukemia. Lancet Oncol. 2003;4:86–94. doi:10.1016/S1470-2045(03)00980-X.
Tallman MS, Hakimian D, Rademaker AW, Zanzig C, Wollins E, Rose E, et al. Relapse of hairy cell leukemia after 2-chlorodeoxyadenosine: long-term follow-up of the Northwestern University experience. Blood. 1996;88:1954–9.
Nieva J, Bethel K, Saven A. Phase 2 study of rituximab in the treatment of cladribine-failed patients with hairy cell leukemia. Blood. 2003;102:810–3. doi:10.1182/blood-2003-01-0014.
Forconi F, Toraldo F, Sozzi E, Amato T, Raspadori D, Lauria F. Complete molecular remission induced by concomitant cladribine-rituximab treatment in a case of multi-resistant hairy cell leukemia. Leuk Lymphoma. 2007;48:2441–3. doi:10.1080/10428190701647903.
Dreger P, Brand R, Milligan D, Corradini P, Finke J, Lambertenghi G, et al. Reduced-intensity conditioning lowers treatment-related mortality of allogeneic stem cell transplantation for chronic lymphocytic leukemia: a population-matched analysis. Leukemia. 2005;19:1029–33. doi:10.1038/sj.leu.2403745.
Cheever MA, Fefer A, Greenberg PD, Appelbaum F, Armitage JO, Buckner CD, et al. Treatment of hairy-cell leukemia with chemoradiotherapy and identical-twin bone-marrow transplantation. N Engl J Med. 1982;307:479–81.
Author information
Authors and Affiliations
Corresponding author
About this article
Cite this article
Kiyasu, J., Shiratsuchi, M., Ohtsuka, R. et al. Achievement of complete remission of refractory hairy cell leukemia by rituximab progressing after allogeneic hematopoietic stem cell transplantation. Int J Hematol 89, 403–405 (2009). https://doi.org/10.1007/s12185-009-0297-2
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12185-009-0297-2